MOXILENS Trademark

Trademark Overview


On Thursday, October 6, 2022, a trademark application was filed for MOXILENS with the United States Patent and Trademark Office. The USPTO has given the MOXILENS trademark a serial number of 97622501. The federal status of this trademark filing is REGISTERED as of Tuesday, April 30, 2024. The MOXILENS trademark is filed in the Pharmaceutical Products category with the following description:

Ocular pharmaceuticals; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists
moxilens

General Information


Serial Number97622501
Word MarkMOXILENS
Filing DateThursday, October 6, 2022
Status700 - REGISTERED
Status DateTuesday, April 30, 2024
Registration Number7375826
Registration DateTuesday, April 30, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 29, 2023

Trademark Statements


Goods and ServicesOcular pharmaceuticals; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists
Pseudo MarkMOXI LENS

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, October 23, 2022
Primary Code005
First Use Anywhere DateMonday, February 1, 2021
First Use In Commerce DateMonday, December 12, 2022

Trademark Owner History


Party NameNOT AVAILABLE
Party Type30 - Original Registrant
Legal Entity Type01 - Individual
AddressSomerville, US 02144

Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressSomerville, US 02144

Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressSomerville, US 02144

Trademark Events


Event DateEvent Description
Wednesday, July 26, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, October 10, 2022NEW APPLICATION ENTERED
Sunday, October 23, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 20, 2023ASSIGNED TO EXAMINER
Wednesday, July 26, 2023EXAMINERS AMENDMENT -WRITTEN
Wednesday, July 26, 2023EXAMINERS AMENDMENT E-MAILED
Wednesday, July 26, 2023EXAMINER'S AMENDMENT ENTERED
Wednesday, July 26, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 9, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 29, 2023PUBLISHED FOR OPPOSITION
Tuesday, August 29, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 24, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, February 1, 2024USE AMENDMENT FILED
Thursday, February 1, 2024TEAS STATEMENT OF USE RECEIVED
Saturday, February 24, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, February 24, 2024STATEMENT OF USE PROCESSING COMPLETE
Wednesday, March 27, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, March 28, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 30, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, April 30, 2024REGISTERED-PRINCIPAL REGISTER